These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 15642373

  • 1. A novel pesticide-induced conformational state of the oestrogen receptor ligand-binding domain, detected by conformation-specific peptide binding.
    Sumbayev VV, Bonefeld-Jørgensen EC, Wind T, Andreasen PA.
    FEBS Lett; 2005 Jan 17; 579(2):541-8. PubMed ID: 15642373
    [Abstract] [Full Text] [Related]

  • 2. Novel modes of oestrogen receptor agonism and antagonism by hydroxylated and chlorinated biphenyls, revealed by conformation-specific peptide recognition patterns.
    Sumbayev VV, Jensen JK, Hansen JA, Andreasen PA.
    Mol Cell Endocrinol; 2008 Jun 11; 287(1-2):30-9. PubMed ID: 18343567
    [Abstract] [Full Text] [Related]

  • 3. Lessons learnt from structural studies of the oestrogen receptor.
    Pike AC.
    Best Pract Res Clin Endocrinol Metab; 2006 Mar 11; 20(1):1-14. PubMed ID: 16522516
    [Abstract] [Full Text] [Related]

  • 4. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site.
    Salvatori L, Pallante P, Ravenna L, Chinzari P, Frati L, Russo MA, Petrangeli E.
    Oncogene; 2003 Jul 31; 22(31):4875-81. PubMed ID: 12894229
    [Abstract] [Full Text] [Related]

  • 5. Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization.
    Ozers MS, Ervin KM, Steffen CL, Fronczak JA, Lebakken CS, Carnahan KA, Lowery RG, Burke TJ.
    Mol Endocrinol; 2005 Jan 31; 19(1):25-34. PubMed ID: 15375189
    [Abstract] [Full Text] [Related]

  • 6. Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif-Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells.
    Bourgoin-Voillard S, Gallo D, Laïos I, Cleeren A, Bali LE, Jacquot Y, Nonclercq D, Laurent G, Tabet JC, Leclercq G.
    Biochem Pharmacol; 2010 Mar 01; 79(5):746-57. PubMed ID: 19879249
    [Abstract] [Full Text] [Related]

  • 7. Structure-function relationship of estrogen receptors in cardiovascular pathophysiological models.
    Arnal JF, Valéra MC, Payrastre B, Lenfant F, Gourdy P.
    Thromb Res; 2012 Oct 01; 130 Suppl 1():S7-11. PubMed ID: 23026669
    [Abstract] [Full Text] [Related]

  • 8. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
    Guzmán CB, Deighton-Collins S, Martinez A, Kleerekoper M, Zhao C, Benjamins JA, Skafar DF.
    Neuro Endocrinol Lett; 2005 Oct 01; 26(5):526-32. PubMed ID: 16264406
    [Abstract] [Full Text] [Related]

  • 9. Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity.
    Burendahl S, Danciulescu C, Nilsson L.
    Proteins; 2009 Dec 01; 77(4):842-56. PubMed ID: 19626711
    [Abstract] [Full Text] [Related]

  • 10. Interactions of ATP, oestradiol, genistein and the anti-oestrogens, faslodex (ICI 182780) and tamoxifen, with the human erythrocyte glucose transporter, GLUT1.
    Afzal I, Cunningham P, Naftalin RJ.
    Biochem J; 2002 Aug 01; 365(Pt 3):707-19. PubMed ID: 12133004
    [Abstract] [Full Text] [Related]

  • 11. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxyl or counterpart hydroxyl with histidine 524 of the human estrogen receptor alpha.
    Aliau S, Mattras H, Richard E, Bonnafous JC, Borgna JL.
    Biochemistry; 2002 Jun 25; 41(25):7979-88. PubMed ID: 12069588
    [Abstract] [Full Text] [Related]

  • 12. Discovery of novel quinoline-based estrogen receptor ligands using peptide interaction profiling.
    Hoekstra WJ, Patel HS, Liang X, Blanc JB, Heyer DO, Willson TM, Iannone MA, Kadwell SH, Miller LA, Pearce KH, Simmons CA, Shearin J.
    J Med Chem; 2005 Mar 24; 48(6):2243-7. PubMed ID: 15771467
    [Abstract] [Full Text] [Related]

  • 13. Targeted mutation of key residues at the start of helix 12 in the hERalpha ligand-binding domain identifies the role of hydrogen-bonding and hydrophobic interactions in the activity of the protein.
    Zhao C, Abrams J, Skafar DF.
    J Steroid Biochem Mol Biol; 2006 Jan 24; 98(1):1-11. PubMed ID: 16191480
    [Abstract] [Full Text] [Related]

  • 14. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
    Kim JH, Lee MH, Kim BJ, Kim JH, Han SJ, Kim HY, Stallcup MR.
    J Mol Endocrinol; 2005 Dec 24; 35(3):449-64. PubMed ID: 16326832
    [Abstract] [Full Text] [Related]

  • 15. Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells.
    Salvatori L, Caporuscio F, Coroniti G, Starace G, Frati L, Russo MA, Petrangeli E.
    J Cell Physiol; 2009 Jul 24; 220(1):35-44. PubMed ID: 19347870
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of transcriptional activity of the oestrogen receptor with sodium iodide symporter as an imaging reporter gene.
    Kang JH, Chung JK, Lee YJ, Kim KI, Jeong JM, Lee DS, Lee MC.
    Nucl Med Commun; 2006 Oct 24; 27(10):773-7. PubMed ID: 16969258
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and crystal structure of a phosphorylated estrogen receptor ligand binding domain.
    Möcklinghoff S, Rose R, Carraz M, Visser A, Ottmann C, Brunsveld L.
    Chembiochem; 2010 Nov 02; 11(16):2251-4. PubMed ID: 20922740
    [No Abstract] [Full Text] [Related]

  • 18. Influence of oestradiol and tamoxifen on oestrogen receptors-alpha and -beta protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells.
    Horner-Glister E, Maleki-Dizaji M, Guerin CJ, Johnson SM, Styles J, White IN.
    J Mol Endocrinol; 2005 Dec 02; 35(3):421-32. PubMed ID: 16326830
    [Abstract] [Full Text] [Related]

  • 19. Activation of alpha- and beta-estrogen receptors by persistent pesticides in reporter cell lines.
    Lemaire G, Mnif W, Mauvais P, Balaguer P, Rahmani R.
    Life Sci; 2006 Aug 15; 79(12):1160-9. PubMed ID: 16626760
    [Abstract] [Full Text] [Related]

  • 20. Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha.
    Dayan G, Lupien M, Auger A, Anghel SI, Rocha W, Croisetière S, Katzenellenbogen JA, Mader S.
    Mol Pharmacol; 2006 Aug 15; 70(2):579-88. PubMed ID: 16679488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.